Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-01-27

Clinical Trial Update: Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)

View source ↗

Summary

A completed clinical trial investigating biomarkers of anti-TNF treatment in inflammatory bowel disease with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Erasmus Medical Center | Conditions: Inflammatory Bowel Diseases | Status: COMPLETED | Results posted: 2022-01-27